Autologous stem cell transplantation is an effective salvage therapy for primary refractory multiple myeloma.
Affiliation
St James's Institute of Oncology, Leeds Teaching Hospitals Trust, Leeds, UKDepartment of Haematology, Hammersmith Hospital, London, UKDepartment of Haematology, The Christie & University of Manchester, Manchester, UKBSBMT Data Registry, Guy's Hospital, London, UKBSBMT Data Registry, Guy's Hospital, London, UKBSBMT Data Registry, Guy's Hospital, London, UKDepartment of Haematology, Queen Elizabeth Hospital, Birmingham, UKDepartment of Haematology, University Hospital of Wales, Cardiff, UKSt James's Institute of Oncology, Leeds Teaching Hospitals Trust, Leeds, UK.Issue Date
2015-04-02
Metadata
Show full item recordCitation
Autologous stem cell transplantation is an effective salvage therapy for primary refractory multiple myeloma. 2015: Biol Blood Marrow TransplantJournal
Biology of Blood and Marrow TransplantationDOI
10.1016/j.bbmt.2015.03.026PubMed ID
25843652Type
ArticleLanguage
enISSN
1523-6536ae974a485f413a2113503eed53cd6c53
10.1016/j.bbmt.2015.03.026
Scopus Count
Collections
Related articles
- A Phase IIb, Multicenter, Open-Label, Safety, and Efficacy Study of High-Dose, Propylene Glycol-Free Melphalan Hydrochloride for Injection (EVOMELA) for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation.
- Authors: Hari P, Aljitawi OS, Arce-Lara C, Nath R, Callander N, Bhat G, Allen LF, Stockerl-Goldstein K
- Issue date: 2015 Dec
- High-Dose Melphalan Plus Thiotepa as Conditioning Regimen before Second Autologous Stem Cell Transplantation for "De Novo" Multiple Myeloma Patients: A Phase II Study.
- Authors: Musso M, Messina G, Marcacci G, Crescimanno A, Console G, Donnarumma D, Scalone R, Pinto A, Martino M
- Issue date: 2015 Nov
- Impact of pretransplant therapy and depth of disease response before autologous transplantation for multiple myeloma.
- Authors: Vij R, Kumar S, Zhang MJ, Zhong X, Huang J, Dispenzieri A, Abidi MH, Bird JM, Freytes CO, Gale RP, Kindwall-Keller TL, Kyle RA, Landsburg DJ, Lazarus HM, Munker R, Roy V, Sharma M, Vogl DT, Wirk B, Hari PN
- Issue date: 2015 Feb
- Outcome of a Salvage Third Autologous Stem Cell Transplantation in Multiple Myeloma.
- Authors: Garderet L, Iacobelli S, Koster L, Goldschmidt H, Johansson JE, Bourhis JH, Krejci M, Leleu X, Potter M, Blaise D, Koenecke C, Peschel C, Radocha J, Metzner B, Lenain P, Schäfer-Eckart K, Pohlreich D, Grasso M, Caillot D, Einsele H, Ladetto M, Schönland S, Kröger N
- Issue date: 2018 Jul
- Single versus tandem high-dose melphalan followed by autologous blood stem cell transplantation in multiple myeloma: long-term results from the phase III GMMG-HD2 trial.
- Authors: Mai EK, Benner A, Bertsch U, Brossart P, Hänel A, Kunzmann V, Naumann R, Neben K, Egerer G, Ho AD, Hillengass J, Raab MS, Neubauer A, Peyn A, Ko YD, Peter N, Scheid C, Goldschmidt H
- Issue date: 2016 Jun